Connect the dots: understanding the SightGlass Vision DOT spectacle lens

The SightGlass DOT 0.2 lens presents a new theory in myopia control, with clinical trial evidence of efficacy in children from 6 to 10 years of age. Diffusion Optics Technology (DOT) incorporates microdots to modulate retinal contrast; it does not employ defocus as for other optical treatments. Learn more here.

The contrast theory: a new approach in understanding myopia

The contrast theory in myopia development and control is based on links between retinal cone expressions, genetics and myopia. This is distinct from peripheral defocus and simultaneous defocus theories and underpins the new SightGlass DOT 0.2 spectacle lens for myopia control. Learn more here.

Is there a dose response in myopia control?

A dose-response is where an increasing amount of a medication or intervention is correlated with a better clinical outcome. When it comes to myopia control, we investigate the evidence for a dose-response with spectacle, contact lens, atropine and outdoor time interventions.

The SightGlass DOT Lens – Q&A with Dr Sherman Tung

Our Q&A format explores new technologies, products and research with experts. In this interview, Dr Sherman Tung, optometrist from Canada, shares his experience with The SightGlass Vision DOT 0.2 Lens in his practice, from prescribing to parent explanations and clinical outcomes.

A successful spectacle lens fitting for myopia

In this case, a colleague has his first experience with the new Essilor Stellest spectacle lens for childhood myopia, with discussion including when to change the prescription and when to stop treatment.

Understanding the new Essilor Stellest spectacle lens

Spectacle lenses which effectively control myopia progression are the next phase in widespread uptake of myopia management. Learn more about the Essilor Stellest lens, from myopia control to vision and visual function outcomes.

The effect of online learning on myopia progression

By using a wearable device to objectively monitor visual behaviour, this study found progression in young myopic children was correlated with less time outdoors, more time working at near for online learning and less time spent wearing their glasses.

Should we fit orthokeratology to a child with trichiasis?

Orthokeratology is effective for myopia control but is it suitable for a child with trichiasis and corneal staining? This case compiles the treatment suggestions for managing a young myopic patient with trichiasis from the Facebook community, with a focus on safety.